Clinical trials
Completed Hepatitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
105 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 7 |
| 2002 | 1 |
| 2003 | 10 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 7 |
| 2012 | 11 |
| 2013 | 9 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 18 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 11 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 7 |
| Dynavax Technologies Corporation | 5 |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| Centers for Disease Control and Prevention | 3 |
| GlaxoSmithKline | 3 |
| Vital Therapies, Inc. | 3 |
| GlobeImmune | 2 |
| Human Genome Sciences Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis | 105 |
| Hepatitis C | 34 |
| Hepatitis B | 19 |
| Hepatitis C, Chronic | 17 |
| Liver Diseases | 17 |
| Hepatitis, Chronic | 12 |
| Hepatitis B, Chronic | 11 |
| Virus Diseases | 11 |
| Fibrosis | 10 |
| Fatty Liver | 8 |
Trials
Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.
5 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.